{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:45:57Z","timestamp":1791927957126,"version":"4.3.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Mucoepidermoid carcinoma (MEC) and adenoid cystic carcinoma (AdCC) are the two most common salivary gland malignancies, but differ substantially in biological behavior, recurrence patterns and long-term prognosis. Comparative data from patients treated within the same institution using similar management strategies remain limited. This study compared long-term survival, recurrence patterns and prognostic factors between MEC and AdCC to identify histology-specific characteristics that may inform follow-up and treatment strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a retrospective cohort study of patients treated for MEC or AdCC at a tertiary academic center between 1996 and 2022. Primary outcomes were overall survival (OS), disease-free survival (DFS) and recurrence patterns, analyzed using Kaplan-Meier curves and multivariable Cox regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Sixty-two patients (31 AdCC, 31 MEC) were included. Although 5-year OS was identical (81%), AdCC had significantly poorer DFS (53% vs. 80%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.015) and higher recurrence rates (18\/31 vs. 8\/31,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.020), and more distant metastases (18\/31 vs. 1\/31 patients,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0016). High tumor grade, defined according to tumor-specific pathological criteria, was the strongest independent predictor of poor outcomes (OS: HR\u2009=\u200919.72,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001; DFS: HR\u2009=\u20093.99,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.01). Advanced T stage, nodal involvement, and metastatic disease independently predicted worse OS. Seven of 11 patients with locoregional recurrence developed a second recurrence, predominantly in AdCC. Curative-intent salvage therapy did not improve OS.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Tumor grade is the strongest prognostic determinant, surpassing histologic subtype. AdCC demonstrates more aggressive biology with higher recurrence rates and poorer DFS despite similar OS. The limited survival benefit of salvage therapy highlights the need for grade-adapted management and more effective therapies for high-grade disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00405-026-10659-1","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:00:19Z","timestamp":1791925219000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The clinical outcomes and overall survival in patients with mucoepidermoid and adenoid cystic carcinoma of the salivary glands: A comparative analysis of long-term outcomes"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9146-2099","authenticated-orcid":false,"given":"Ido","family":"Amir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2178-8971","authenticated-orcid":false,"given":"Nir","family":"Tsur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8211-9774","authenticated-orcid":false,"given":"Eyal","family":"Yosefof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6231-8975","authenticated-orcid":false,"given":"Gideon","family":"Bachar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiman","family":"Elmograbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0654-1161","authenticated-orcid":false,"given":"Dan","family":"Yaniv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3078-6868","authenticated-orcid":false,"given":"Noga","family":"Kurman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esmat","family":"Najjar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,13]]},"reference":[{"issue":"10","key":"10659_CR1","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1001\/jamaoto.2015.1745","volume":"141","author":"RJ Lee","year":"2015","unstructured":"Lee RJ, Tan AP, Tong EL, Satyadev N, Christensen RE, Epidemiology (2015) Prognostic Factors, and Treatment of Malignant Submandibular Gland Tumors: A Population-Based Cohort Analysis. JAMA Otolaryngology\u2013Head Neck Surg 141(10):905\u2013912. https:\/\/doi.org\/10.1001\/jamaoto.2015.1745","journal-title":"JAMA Otolaryngology\u2013Head Neck Surg"},{"issue":"1","key":"10659_CR2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2334\/josnusd.58.67","volume":"58","author":"J Ata-Ali","year":"2016","unstructured":"Ata-Ali J, Zurriaga O, Alberich C (2016) Incidence and survival rates for malignant salivary gland tumors. J Oral Sci 58(1):67\u201373. https:\/\/doi.org\/10.2334\/josnusd.58.67","journal-title":"J Oral Sci"},{"issue":"6","key":"10659_CR3","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/S0194-5998(99)70323-2","volume":"120","author":"JA Pinkston","year":"1999","unstructured":"Pinkston JA, Cole P (1999) Incidence rates of salivary gland tumors: results from a population-based study. Otolaryngol Head Neck Surg 120(6):834\u2013840. https:\/\/doi.org\/10.1016\/S0194-5998(99)70323-2","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"19","key":"10659_CR4","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.1002\/CNCR.32208","volume":"125","author":"AJ Hay","year":"2019","unstructured":"Hay AJ, Migliacci J, Karassawa Zanoni D, McGill M, Patel S, Ganly I (2019) Minor salivary gland tumors of the head and neck\u2014Memorial Sloan Kettering experience: Incidence and outcomes by site and histological type. Cancer 125(19):3354\u20133366. https:\/\/doi.org\/10.1002\/CNCR.32208","journal-title":"Cancer"},{"key":"10659_CR5","doi-asserted-by":"publisher","first-page":"106484","DOI":"10.1016\/j.oraloncology.2023.106484","volume":"144","author":"E Hofmann","year":"2023","unstructured":"Hofmann E, Priebe J, Rieke DT et al (2023) Prognostic factors in surgically treated malignant salivary gland tumors. Oral Oncol 144:106484. https:\/\/doi.org\/10.1016\/j.oraloncology.2023.106484","journal-title":"Oral Oncol"},{"issue":"3","key":"10659_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s11864-021-00820-9","volume":"22","author":"NP Joshi","year":"2021","unstructured":"Joshi NP, Broughman JR (2021) Postoperative Management of Salivary Gland Tumors. Curr Treat Options Oncol 22(3):23. https:\/\/doi.org\/10.1007\/s11864-021-00820-9","journal-title":"Curr Treat Options Oncol"},{"issue":"3","key":"10659_CR7","doi-asserted-by":"publisher","first-page":"206","DOI":"10.14639\/0392-100X-N1379","volume":"41","author":"G Cant\u00f9","year":"2021","unstructured":"Cant\u00f9 G (2021) Adenoid cystic carcinoma. An indolent but aggressive tumour. Part A: from aetiopathogenesis to diagnosis. Acta Otorhinolaryngol Ital 41(3):206\u2013214. https:\/\/doi.org\/10.14639\/0392-100X-N1379","journal-title":"Acta Otorhinolaryngol Ital"},{"issue":"3","key":"10659_CR8","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1158\/1078-0432.CCR-20-1192","volume":"27","author":"R Ferrarotto","year":"2021","unstructured":"Ferrarotto R, Mitani Y, McGrail DJ et al (2021) Proteogenomic Analysis of Salivary Adenoid Cystic Carcinomas Defines Molecular Subtypes and Identifies Therapeutic Targets. Clin Cancer Res 27(3):852\u2013864. https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-1192","journal-title":"Clin Cancer Res"},{"issue":"7","key":"10659_CR9","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.1007\/s00405-023-07940-y","volume":"280","author":"M Westergaard-Nielsen","year":"2023","unstructured":"Westergaard-Nielsen M, Godballe C, Eriksen JG et al (2023) Epidemiology, outcomes, and prognostic factors in submandibular gland carcinomas: a national DAHANCA study. Eur Arch Otorhinolaryngol 280(7):3405\u20133413. https:\/\/doi.org\/10.1007\/s00405-023-07940-y","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"1","key":"10659_CR10","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.oraloncology.2014.10.007","volume":"51","author":"S van Weert","year":"2015","unstructured":"van Weert S, van der Waal I, Witte BI, Leemans CR, Bloemena E (2015) Histopathological grading of adenoid cystic carcinoma of the head and neck: analysis of currently used grading systems and proposal for a simplified grading scheme. Oral Oncol 51(1):71\u201376. https:\/\/doi.org\/10.1016\/j.oraloncology.2014.10.007","journal-title":"Oral Oncol"},{"issue":"6","key":"10659_CR11","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3322\/caac.21807","volume":"73","author":"CE Steuer","year":"2023","unstructured":"Steuer CE, Hanna GJ, Viswanathan K et al (2023) The evolving landscape of salivary gland tumors. Cancer J Clin 73(6):597\u2013619. https:\/\/doi.org\/10.3322\/caac.21807","journal-title":"Cancer J Clin"},{"issue":"4","key":"10659_CR12","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.3390\/cancers15041236","volume":"15","author":"H Nishida","year":"2023","unstructured":"Nishida H, Kusaba T, Kawamura K, Oyama Y, Daa T (2023) Histopathological Aspects of the Prognostic Factors for Salivary Gland Cancers. Cancers (Basel) 15(4):1236 Published 2023 Feb 15. https:\/\/doi.org\/10.3390\/cancers15041236","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10659_CR13","doi-asserted-by":"publisher","first-page":"103135","DOI":"10.1016\/j.amjoto.2021.103135","volume":"42","author":"JM Soffer","year":"2021","unstructured":"Soffer JM, Nassif SJ, Von Plato M, Chisholm J, O\u2019Leary MA (2021) Survival and prognostic factors of salivary gland malignant mixed tumor-not otherwise specified: A population-based analysis. Am J Otolaryngol 42(6):103135. https:\/\/doi.org\/10.1016\/j.amjoto.2021.103135","journal-title":"Am J Otolaryngol"},{"issue":"5","key":"10659_CR14","doi-asserted-by":"publisher","first-page":"e218","DOI":"10.4317\/jced.51143","volume":"5","author":"AO Lawal","year":"2013","unstructured":"Lawal AO, Adisa AO, Kolude B, Adeyemi BF, Olajide MA (2013) A review of 413 salivary gland tumours in the head and neck region. J Clin Exp Dent 5(5):e218\u2013e222. https:\/\/doi.org\/10.4317\/jced.51143","journal-title":"J Clin Exp Dent"},{"issue":"4","key":"10659_CR15","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s12105-022-01459-0","volume":"16","author":"I Alsanie","year":"2022","unstructured":"Alsanie I, Rajab S, Cottom H et al (2022) Distribution and Frequency of Salivary Gland Tumours: An International Multicenter Study. Head Neck Pathol 16(4):1043\u20131054. https:\/\/doi.org\/10.1007\/s12105-022-01459-0","journal-title":"Head Neck Pathol"},{"issue":"7","key":"10659_CR16","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1001\/jamaoto.2013.3347","volume":"139","author":"S Ali","year":"2013","unstructured":"Ali S, Palmer FL, Yu C et al (2013) A Predictive Nomogram for Recurrence of Carcinoma of the Major Salivary Glands. JAMA Otolaryngology\u2013Head Neck Surg 139(7):698\u2013705. https:\/\/doi.org\/10.1001\/jamaoto.2013.3347","journal-title":"JAMA Otolaryngology\u2013Head Neck Surg"},{"key":"10659_CR17","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3389\/fonc.2018.00153","volume":"8","author":"V Kumar","year":"2018","unstructured":"Kumar V, Soni P, Garg M et al (2018) A Comparative Study of Primary Adenoid Cystic and Mucoepidermoid Carcinoma of Lung. Front Oncol 8:153. https:\/\/doi.org\/10.3389\/fonc.2018.00153","journal-title":"Front Oncol"},{"key":"10659_CR18","doi-asserted-by":"publisher","unstructured":"Pardis S, Zare R, Jaafari-ashkavandi Z, Ashraf MJ, Khademi B (2016) Twist expression in pleomorphic adenoma, adenoid cystic carcinoma and mucoepidermoid carcinoma of salivary glands. TJPATH. https:\/\/doi.org\/10.5146\/tjpath.2015.01343","DOI":"10.5146\/tjpath.2015.01343"},{"issue":"8","key":"10659_CR19","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1097\/00005537-200108000-00011","volume":"111","author":"MD Gibbons","year":"2001","unstructured":"Gibbons MD, Manne U, Carroll WR, Peters GE, Weiss HL, Grizzle WE (2001) Molecular differences in mucoepidermoid carcinoma and adenoid cystic carcinoma of the major salivary glands. Laryngoscope 111(8):1373\u20131378. https:\/\/doi.org\/10.1097\/00005537-200108000-00011","journal-title":"Laryngoscope"},{"issue":"7","key":"10659_CR20","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1002\/hed.27376","volume":"45","author":"MB Hacioglu","year":"2023","unstructured":"Hacioglu MB, Erdogan B, Bardakc\u0131 M et al (2023) Major and minor salivary gland cancers: A multicenter retrospective study. Head Neck 45(7):1643\u20131653. https:\/\/doi.org\/10.1002\/hed.27376","journal-title":"Head Neck"},{"issue":"19","key":"10659_CR21","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.1002\/cncr.32208","volume":"125","author":"AJ Hay","year":"2019","unstructured":"Hay AJ, Migliacci J, Karassawa Zanoni D, McGill M, Patel S, Ganly I (2019) Minor salivary gland tumors of the head and neck-Memorial Sloan Kettering experience: Incidence and outcomes by site and histological type. Cancer 125(19):3354\u20133366. https:\/\/doi.org\/10.1002\/cncr.32208","journal-title":"Cancer"},{"issue":"1","key":"10659_CR22","doi-asserted-by":"publisher","first-page":"15821","DOI":"10.1038\/s41598-024-66709-3","volume":"14","author":"J Tasoulas","year":"2024","unstructured":"Tasoulas J, Schrank TP, Bharambe H et al (2024) Molecular characterization of the salivary adenoid cystic carcinoma immune landscape by anatomic subsites. Sci Rep 14(1):15821. https:\/\/doi.org\/10.1038\/s41598-024-66709-3","journal-title":"Sci Rep"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-026-10659-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00405-026-10659-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-026-10659-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:00:19Z","timestamp":1791925219000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00405-026-10659-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,13]]},"references-count":22,"alternative-id":["10659"],"URL":"https:\/\/doi.org\/10.1007\/s00405-026-10659-1","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,13]]},"assertion":[{"value":"7 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the institutional review committee of the participating institution under protocol number RMC-0731-21. Patient data were handled in accordance with institutional guidelines and the principles of the Decleration of Helsinki.","order":1,"name":"Ethics","label":"Ethics statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}